Skip to main navigation Skip to search Skip to main content

The effect of alogliptin and pioglitazone combination therapy on various aspects of beta-cell function in patients with recent-onset type 2 diabetes

  • D.H. van Raalte
  • , R.E. van Genugten
  • , B. Eliasson
  • , D.L. Moller-Goede
  • , A. Mari
  • , A. Tura
  • , C. Wilson
  • , P. Fleck
  • , M.R. Taskinen
  • , U. Smith
  • , M. Diamant

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)565-574
JournalEuropean Journal of Endocrinology
Volume170
Issue number4
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this